Liu JF - Search Results

1

Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.

Zhen Q, Liu JF, Liu JB, Wang RF, Chu WW, Zhang YX, Tan GL, Zhao XJ, Lv BL. Zhen Q, et al. Among authors: liu jb, liu jf. Cancer Biol Ther. 2015;16(4):549-57. doi: 10.1080/15384047.2015.1016689. Epub 2015 Apr 1. Cancer Biol Ther. 2015. PMID: 25831463 Free PMC article.

2

Inhibitory effect of 11-carbonyl-beta-boswellic acid on non-small cell lung cancer H446 cells.

Huang G, Yang J, Zhang L, Cao L, Zhang M, Niu X, Zhou Z, Zhang X, Li P, Liu JF. Huang G, et al. Among authors: liu jf. Biochem Biophys Res Commun. 2018 Sep 18;503(4):2202-2205. doi: 10.1016/j.bbrc.2018.06.137. Epub 2018 Jul 4. Biochem Biophys Res Commun. 2018. PMID: 29953860

3

Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study.

Liu JF, Sun XS, Yin JH, Xu XE. Liu JF, et al. Front Oncol. 2023 Mar 13;13:1132854. doi: 10.3389/fonc.2023.1132854. eCollection 2023. Front Oncol. 2023. PMID: 36994198 Free PMC article.

4

LncRNA NONHSAT227443.1 Confers Esophageal Squamous Cell Carcinoma Chemotherapy Resistance by Activating PI3K/AKT Signaling via Targeting MRTFB.

Wang Y, Wang Y, Zhang J, Shi Z, Liu J. Wang Y, et al. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241274369. doi: 10.1177/15330338241274369. Technol Cancer Res Treat. 2024. PMID: 39150441 Free PMC article.

5

The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo.

Liu JF, Zhang SW, Jamieson GG, Zhu GJ, Wu TC, Zhu TN, Shan BE, Drew PA. Liu JF, et al. Int J Cancer. 2008 Apr 1;122(7):1639-44. doi: 10.1002/ijc.23288. Int J Cancer. 2008. PMID: 18058818 Clinical Trial.

6

NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.

Liu JF, Zhu GJ, Jamieson GG, Wu TC, Zhu TN, Shan BE, Drew PA. Liu JF, et al. Cancer Invest. 2009 Jan;27(1):17-23. doi: 10.1080/07357900801992913. Cancer Invest. 2009. PMID: 19160097

7

Non-steroidal anti-inflammatory drugs and cancer, with an especial focus on esophageal cancer.

Liu JF. Liu JF. Asian Pac J Cancer Prev. 2011;12(12):3159-68. Asian Pac J Cancer Prev. 2011. PMID: 22471447 Free article. Review.

8

The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.

Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma M, Liu JF. Du YY, et al. Among authors: liu jf. J Gastroenterol Hepatol. 2016 Feb;31(2):384-93. doi: 10.1111/jgh.13180. J Gastroenterol Hepatol. 2016. PMID: 26414725

9

The effect of celecoxib on DNA methylation of CDH13, TFPI2, and FSTL1 in squamous cell carcinoma of the esophagus in vivo.

Liu JF, Li YS, Drew PA, Zhang C. Liu JF, et al. Anticancer Drugs. 2016 Oct;27(9):848-53. doi: 10.1097/CAD.0000000000000396. Anticancer Drugs. 2016. PMID: 27400374 Clinical Trial.

10

A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus.

Wang Y, Liu JF. Wang Y, et al. Among authors: liu jf. Onco Targets Ther. 2017 May 5;10:2453-2459. doi: 10.2147/OTT.S115637. eCollection 2017. Onco Targets Ther. 2017. PMID: 28503068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,689 results

Search Page

Filters